Overview

A Study of LY3337641 in Rheumatoid Arthritis

Status:
Terminated
Trial end date:
2018-08-15
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety and effectiveness of LY3337641 in adults with rheumatoid arthritis (RA).
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company